Cover Image

Pharmacogenomics in the Management of Pulmonary Arterial Hypertension: Current Perspectives

James C Coons,1,2 Philip E Empey1 1Department of Pharmacy and Therapeutics, University of Pittsburgh School of Pharmacy, Pittsburgh, PA, USA; 2Department of Pharmacy, UPMC Presbyterian-Shadyside Hospital, Pittsburgh, PA, USACorrespondence: James C Coons, Email jccoons@pitt.eduAbstract: Pulmonary art...

Full description

Saved in:

Bibliographic Details
Main Authors:	Coons JC (Author), Empey PE (Author)
Format:	Book
Published:	Dove Medical Press, 2023-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Management Considerations for Pulmonary Arterial Hypertension Pharmacotherapy in the Intensive Care Unit
by: Elizabeth M. Foster, et al.
Published: (2023)

Pharmacogenomics And Hypertension: Current Insights
by: Oliveira-Paula GH, et al.
Published: (2019)

Pharmacogenomics In Pharmacy Practice: Current Perspectives
by: Elewa H, et al.
Published: (2019)

Medical Management of Pulmonary Arterial Hypertension: Current Approaches and Investigational Drugs
by: Qi Jin, et al.
Published: (2023)

Prostanoid therapies in the management of pulmonary arterial hypertension
by: LeVarge BL
Published: (2015)

The Pharmacogenomics of Anti-Hypertensive Therapy
by: Sandosh Padmanabhan, et al.
Published: (2010)

Safety and tolerability of bosentan in the management of pulmonary arterial hypertension
by: Kari E Roberts, et al.
Published: (2009)

The limits of oral therapy in pulmonary arterial hypertension management
by: Liu QQ, et al.
Published: (2015)

Management of Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis
by: Almaaitah S, et al.
Published: (2020)

Pulmonary Arterial Hypertension in Indonesia: Current Status and Local Application of International Guidelines
by: Lucia Kris Dinarti, et al.
Published: (2021)

Current clinical evidence on pioglitazone pharmacogenomics
by: Marina eKawaguchi-Suzuki, et al.
Published: (2013)

Intravenous Epoprostenol for Management of Pulmonary Arterial Hypertension during Pregnancy
by: Julia Timofeev, et al.
Published: (2013)

Bioactivities and mechanisms of natural medicines in the management of pulmonary arterial hypertension
by: Zhijie Yu, et al.
Published: (2022)

Current perspectives on treatment of hypertensive patients with chronic obstructive pulmonary disease
by: Chandy D, et al.
Published: (2013)

Current perspectives on combination therapy in the management of hypertension
by: Mallat SG, et al.
Published: (2013)

Immunity and inflammation in pulmonary arterial hypertension: From pathophysiology mechanisms to treatment perspective
by: Ran-ran Wang, et al.
Published: (2022)

Early intervention in the management of pulmonary arterial hypertension: clinical and economic outcomes
by: Burger CD, et al.
Published: (2017)

Cardiopulmonary exercise testing in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
by: Alexis Coulis, et al.
Published: (2024)

Genetics and Genomics of Pulmonary Arterial Hypertension
Published: (2022)

Ambrisentan for the treatment of pulmonary arterial hypertension
by: Brian Casserly, et al.
Published: (2008)

Proteomic analysis of pulmonary arterial hypertension
by: Xiaohan Qin, et al.
Published: (2021)

Drug-induced pulmonary artery hypertension
by: O. D. Ostroumova, et al.
Published: (2022)

Dietary intervention in the management of phenylketonuria: current perspectives
by: Rocha JC, et al.
Published: (2016)

Information Experiences and Needs in Patients with Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension
by: Bodil Ivarsson, et al.
Published: (2014)

Pulmonary arteriovenous malformations with pulmonary artery hypertension: Therapeutic implication
by: Jayachandra, et al.
Published: (2020)

Future Perspectives of Pulmonary Arterial Hypertension: A Review of Novel Pipeline Treatments and Indications
by: Maria Eugenia Novara, et al.
Published: (2024)

Anomalous origin of branch pulmonary artery from the aorta: Current challenges in the management
by: Jeeva Vijayan, et al.
Published: (2023)

Switching Strategy in the Management of Patients with Pulmonary Arterial Hypertension. The REPLACE Study Results
by: E. V. Filippov
Published: (2020)

Update on pulmonary arterial hypertension in children: management strategies and clinical utility of sildenafil
by: Wardle A, et al.
Published: (2012)

Treatment-resistant schizophrenia: current insights on the pharmacogenomics of antipsychotics
by: Lally J, et al.
Published: (2016)

Pharmacogenomics DNA Biomarkers in Colorectal Cancer: Current Update
by: Nurul-Syakima Ab Mutalib, et al.
Published: (2017)

Pharmacogenomics of Hypertension and Preeclampsia: Focus on Gene-Gene Interactions
by: Marcelo R. Luizon, et al.
Published: (2018)

Update on the pharmacogenomics of pain management
by: Kaye AD, et al.
Published: (2019)

Quality of life in patients with pulmonary arterial hypertension
by: Mirosława Anna Kowalkowska, et al.
Published: (2023)

Principles of pharmacological correction of pulmonary arterial hypertension
by: Mikhail Korokin, et al.
Published: (2018)

Sotatercept for Pulmonary Arterial Hypertension in the Inpatient Setting
by: Heather Torbic PharmD, FCCM, BCPS, BCCCP, et al.
Published: (2024)

Novel and emerging therapies in pulmonary arterial hypertension
by: Steven J. Cassady, et al.
Published: (2022)

Recent Advances in the Treatment of Pulmonary Arterial Hypertension
by: Naoyuki Otani, et al.
Published: (2022)

The Pulmonary Artery Pulsatility Index Provides No Additional Prognostic Information in Pediatric Pulmonary Arterial Hypertension
by: Faye E. Smits, et al.
Published: (2024)

Pulmonary arterial hypertension due to antiphospholipid syndrome initially mimicking chronic thromboembolic pulmonary hypertension
by: Jina Yeo, et al.
Published: (2022)